Explore more topics
SEC Form 4 research

Homology Medicines, Inc. insider transactions

Inspect Homology Medicines, Inc.'s public SEC insider acquisitions and sales, reporting owners and source receipts.

As of 2026-10-15T08:02:39.132Z

Issuer CIK
0001661998
Reporting owners
78
Officers and directors
19
Jump to a section

What is a Form 4?

Animation: what a Form 4 is, shown with one real example. Sonic Automotive (SAH) reporting owner Paul P. Rusnak bought 13,701 shares at $59.78 on Wednesday, October 7, 2026, transaction code P, an open-market purchase (S is a sale and A is an award from the company). A timeline marks the SEC's two-business-day filing deadline, which ends Friday, October 9. The SEC accepted the Form 4 at 4:33:21 PM ET on October 9, and NexusTrade treats it as public one minute later, at 4:34:21 PM ET. A lamp for NexusTrade's InsiderTrades indicator stays off from the trade date until that moment, then counts one purchase worth 13,701 × $59.78 = $819,045.78.
In this example the shares were bought on Oct 7, 2026, and NexusTrade's InsiderTrades indicator can count the purchase starting at 4:34:21 PM ET on Oct 9, one minute after the SEC accepted the Form 4.

A Form 4 is the SEC filing a company insider, such as an officer, director or 10% owner, uses to report a trade in the company's stock, generally within two business days. The animation follows one real filing as an example: Paul P. Rusnak's purchase of Sonic Automotive (SAH) shares on October 7, 2026.

The same reading applies to every row on this page. The trade date is when the shares changed hands. The available date is when NexusTrade treats the filing as public, and a NexusTrade InsiderTrades indicator counts a purchase (code P) or sale (code S) only from that moment. Code A awards are not counted as purchases.

Read one actual disclosure before using it

Show the table · 1 row, 7 columns

Scroll sideways to compare all columns. Select a heading to sort.

2026-08-282026-08-25Kalowski LeeS3,972$16.56Not reported

First displayed source row from Recent insider disclosures. The full bounded history and coverage notes remain below.

The displayed observation date is 2026-08-25 and its public availability date is 2026-08-28. Subtracting those calendar dates gives 3 days of disclosure lag. Historical public research can use the record from the availability date, rather than backdating knowledge to the observation date. The calendar-day difference does not assert an intraday publication time.

This row is code S: a sale. A purchase-following rule excludes this sale even if the reported dollar amount is large.

Open the linked original receipts to verify the row, then inspect a second record before drawing a pattern. This public filing observation supplies source evidence, not a completed copy-trading return.

Recent insider disclosures

Inspect all 14 displayed rows: Recent insider disclosures

This table includes purchases, sales and awards in the public filing record. Awards and open-market purchases are distinct transaction codes. For historical research, use the public availability date to determine when the transaction was knowable.

Read code P as a purchase, S as a sale and A as an award. An award is an acquisition, but it is not an open-market purchase. Open the filing receipt to check the transaction details.

Scroll sideways to compare all columns. Select a heading to sort.

2026-08-282026-08-25Kalowski LeeS3,972$16.56Not reported
2026-08-282026-08-25Morrison Jodie PopeS9,845$16.56Not reported
2026-08-282026-08-25Violette Shelia M.S2,798$16.56Not reported
2026-07-222026-06-12TZIANABOS ARTHURA10,826$0Not reported
2026-07-222026-06-12Lundberg Sven AnteA10,826$0Not reported
2026-07-222026-06-12LAPORTE KATHLEENA10,826$0Not reported
2026-07-222026-06-12Iwicki Mark TA10,826$0Not reported
2026-07-222026-06-12Xu DiyongA10,826$0Not reported
2026-07-222026-06-12Manke IsaacA10,826$0Not reported
2026-07-222026-06-12GRAYZEL DAVID S.A10,826$0Not reported
2026-07-222026-06-12Thistle MaryA10,826$0Not reported
2026-07-212026-07-16Violette Shelia M.A37,500$0Not reported
2026-07-212026-07-16Morrison Jodie PopeA132,000$0Not reported
2026-07-212026-07-16Kalowski LeeA53,250$0Not reported

Most recent 90-day source activity, up to 50 rows. No rows means no matching recent records, not no historical activity.

Officers and directors in the directory

Inspect all 26 displayed rows: Officers and directors in the directory

Scroll sideways to compare all columns. Select a heading to sort.

OrbiMed Genesis GP LLC0001808744218
Jordan Julie00019685545
Morrison Jodie Pope00016182478
Deerfield Private Design Fund III, L.P.0001603333208
Seymour Albert000173532416
Deerfield Healthcare Innovations Fund, L.P.000164698191
Deerfield Mgmt HIF, L.P.000166573691
Smith W Bradford000131767822
Alloway Paul00019161554
Blum Michael Lee00019165001
Cohn Gabriel00017947021
DEERFIELD MANAGEMENT COMPANY, L.P.00010092581,346
Deerfield Mgmt III, L.P.0001610540208
Deerfield Mgmt L.P.00010108231,304
DEERFIELD PARTNERS, L.P.0001301041636
Flynn James E00013525461,356
Kalowski Lee000161827324
Kelly Timothy P000175406712
Michaud Charles Jr00019990112
ORBIMED ADVISORS LLC00010559511,020
OrbiMed Capital GP VII LLC0001760648191
PARMAR KUSH0001664281106
Rasty Siyamak00017354502
TZIANABOS ARTHUR000158622623
Violette Shelia M.00020161443
Xu Diyong00019950882

Which transactions qualify for the company tracker

The company strategy uses verified officers and directors with qualifying acquisitions at this issuer. Other reporting owners may appear in source records without becoming strategy signals.

Strategy eligibility is held while filing coverage is unresolved.

Historical follower simulations are separate from these source transactions. They do not establish live trading results.